Seres Therapeutics, Inc. (MCRB)
14.31
-0.32
(-2.19%)
USD |
NASDAQ |
Feb 10, 16:00
14.27
-0.04
(-0.28%)
After-Hours: 20:00
Seres Therapeutics Market Cap : 125.28M for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Altimmune, Inc. | 486.24M |
| ACADIA Pharmaceuticals, Inc. | 3.840B |
| Alnylam Pharmaceuticals, Inc. | 42.67B |
| Savara, Inc. | 1.072B |
| BioMarin Pharmaceutical, Inc. | 11.46B |
Market Cap Related Metrics
| PE Ratio | 23.57 |
| PS Ratio | 355.51 |
| Price to Book Value | 2.867 |
| Price | 14.31 |
| Earnings Yield | 4.24% |
| Normalized PE Ratio | 23.58 |